Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Neuromuscular Disorders : NMD
|
January 29, 2025
Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD)
M Porcino, O Musumeci, C Usbergo, et al.
Neuromuscular Disorders : NMD
|
May 9, 2018
A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations
M Keßler, A Kieltsch, E Kayvanpour, et al.
Neurology
|
August 19, 2009
Consequences of mutations within the C terminus of the FHL1 gene
B Schoser, H H Goebel, I Janisch, et al.
Journal of Neurology
|
September 23, 2008
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany
T Suominen, B Schoser, O Raheem, et al.
Journal of Neurology
|
December 22, 2010
Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration
J Schessl, M Schuberth, P Reilich, et al.
Neuromuscular Disorders : NMD
|
January 24, 2018
Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey
A C Jiménez-Moreno, J Raaphorst, H Babačić, et al.
Neuromuscular Disorders : NMD
|
May 11, 2006
140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management
B Udd, G Meola, R Krahe, et al.
International Journal of Cardiology
|
December 26, 2012
The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes
V A Sansone, E Brigonzi, B Schoser, et al.
Der Nervenarzt
|
November 23, 2013
[Diagnosis and therapy of late onset Pompe disease]
A Schüller, C Kornblum, M Deschauer, et al.
Molecular Genetics and Metabolism
|
July 16, 2013
Pain in adult patients with Pompe disease: a cross-sectional survey
D Güngör, A K Schober, M E Kruijshaar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Neuromuscular Disorders : NMD
|
January 29, 2025
Management of presymptomatic juvenile patients with late-onset Pompe disease (LOPD)
M Porcino, O Musumeci, C Usbergo, et al.
Neuromuscular Disorders : NMD
|
May 9, 2018
A zebrafish model for FHL1-opathy reveals loss-of-function effects of human FHL1 mutations
M Keßler, A Kieltsch, E Kayvanpour, et al.
Neurology
|
August 19, 2009
Consequences of mutations within the C terminus of the FHL1 gene
B Schoser, H H Goebel, I Janisch, et al.
Journal of Neurology
|
September 23, 2008
High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany
T Suominen, B Schoser, O Raheem, et al.
Journal of Neurology
|
December 22, 2010
Long-term efficiency of intravenously administered immunoglobulin in anti-Yo syndrome with paraneoplastic cerebellar degeneration
J Schessl, M Schuberth, P Reilich, et al.
Neuromuscular Disorders : NMD
|
January 24, 2018
Falls and resulting fractures in Myotonic Dystrophy: Results from a multinational retrospective survey
A C Jiménez-Moreno, J Raaphorst, H Babačić, et al.
Neuromuscular Disorders : NMD
|
May 11, 2006
140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management
B Udd, G Meola, R Krahe, et al.
International Journal of Cardiology
|
December 26, 2012
The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long-term outcomes
V A Sansone, E Brigonzi, B Schoser, et al.
Der Nervenarzt
|
November 23, 2013
[Diagnosis and therapy of late onset Pompe disease]
A Schüller, C Kornblum, M Deschauer, et al.
Molecular Genetics and Metabolism
|
July 16, 2013
Pain in adult patients with Pompe disease: a cross-sectional survey
D Güngör, A K Schober, M E Kruijshaar, et al.
Page
of 4